Latanoprost Side Effects
Latanoprost commonly causes ocular side effects including conjunctival hyperemia (redness), increased eyelash growth and pigmentation, and iris darkening, while rare but serious effects include cystoid macular edema, uveitis, and severe cutaneous reactions.
Common Side Effects (5-30% of patients)
Ocular Effects
The FDA label 1 and clinical guidelines 2 identify these frequent ocular side effects:
- Conjunctival hyperemia (redness) - occurs in approximately 30% of patients but rarely requires discontinuation (<1%) 1, 3
- Eyelash changes - hypertrichosis (increased length, thickness, pigmentation, and number) develops in the majority of patients using latanoprost for more than 6 months 3
- Blurred vision, burning and stinging - reported in 5-15% of patients 1
- Foreign body sensation and itching - common complaints in 5-15% 1
- Punctate epithelial keratopathy - mild corneal surface changes 1
- Increased iris pigmentation - occurs in 12-18% of Caucasians over 1-2 years, more common in Asian populations, and is permanent even after discontinuation 3
Less Common Ocular Effects (1-4%)
- Dry eye, excessive tearing, eye pain
- Lid crusting, discomfort, edema, and erythema
- Eyelid skin darkening 1
- Photophobia 1
Systemic Effects
- Upper respiratory tract infection/cold/flu - approximately 4% 1
- Chest pain/angina pectoris - 1-2% 1; notably, a 2024 pharmacovigilance study found latanoprost specifically linked to cardiac events including angina pectoris and atrial tachycardia 4
- Muscle/joint/back pain - 1-2% 1
- Rash/allergic skin reactions - 1-2% 1
Rare but Serious Side Effects (<1%)
Vision-Threatening Complications
- Cystoid macular edema - particularly in pseudophakic and aphakic patients; causal relationship not definitively proven but well-documented 1, 3, 5
- Anterior uveitis/iritis - intraocular inflammation requiring monitoring 1, 5
- Reactivation of herpes simplex keratitis - reported in postmarketing surveillance 1, 5
- Corneal edema and erosions 1
- Retinal artery embolus, retinal detachment (extremely rare during clinical studies) 1
Severe Cutaneous Reactions
- Toxic epidermal necrolysis - life-threatening skin reaction 1
- Severe blistering rash - a 2018 case report documented severe cutaneous blistering on eyelids, neck, and hands from direct contact with latanoprost drops 6
Systemic Hypersensitivity
A 2024 pharmacovigilance study analyzing 30,853 reports found hypersensitivity reactions were the most common systemic adverse events reported with prostaglandin analogs as a class 4
Other Rare Systemic Effects
- Asthma and exacerbation of asthma 1
- Dyspnea (shortness of breath) 1
- Dizziness and headache 1, 7
- Meniere's disease (latanoprost-specific association) 4
Important Clinical Caveats
Pigmentation changes are permanent: Iris hyperpigmentation is caused by increased melanogenesis, not melanocyte proliferation, and remains unchanged after discontinuation 3. Patients must be counseled about this irreversible cosmetic change before starting therapy.
Preservative-related effects: Many side effects, particularly ocular surface disease symptoms, may be related to benzalkonium chloride preservative rather than latanoprost itself. Preservative-free formulations show improved tolerability while maintaining equivalent IOP-lowering efficacy 8.
Population considerations: The 2024 pharmacovigilance study found adverse events predominantly in elderly and female patients 4, suggesting these populations may require closer monitoring.
Pupillary effects: A 2024 longitudinal study demonstrated that long-term latanoprost treatment causes decreased velocity of pupil dilation and mild mydriatic effects, though clinical significance remains unclear 9.